Thallium-201 single-photon emission tomography in the treatment follow-up of nasopharyngeal carcinoma
Takashi Togawa(Chiba Cancer Center), Tatsuaki Katahashi(Chiba Cancer Center), Yousuke Takeuchi(Chiba Cancer Center), Yuichi Sekiya(Chiba Cancer Center), Fumiyuki SHIMADA(Chiba Cancer Center), Nobuharu Yui(Chiba Cancer Center), Ken Omura(Ebina General Hospital), Kazuo Hatano(Astellas Pharma (Japan)), Masamichi Yanagisawa(Chiba Cancer Center), F Kinoshita(Chiba Cancer Center)
Cited by 2
Related Papers
Exploration of Tumor-Suppressive MicroRNAs Silenced by DNA Hypermethylation in Oral Cancer
|Cancer Research|2008|618
Current status of oral cancer treatment strategies: surgical treatments for oral squamous cell carcinoma
|International Journal of Clinical Oncology|2014|263
Phase II trial of gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR-mutant lung adenocarcinoma
|Lung Cancer|2013|261
The Tumor Suppressive MicroRNA <i>miR-218</i> Targets the mTOR Component <i>Rictor</i> and Inhibits AKT Phosphorylation in Oral Cancer
|Cancer Research|2011|250
Differential binding properties of B7-H1 and B7-DC to programmed death-1
|Biochemical and Biophysical Research Communications|2003|206